S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
NASDAQ:KALV

KalVista Pharmaceuticals SEC Filings & 10K Form

$13.63
-0.87 (-6.00%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.60
▼
$14.96
50-Day Range
$14.50
▼
$20.20
52-Week Range
$13.60
▼
$45.00
Volume
455,962 shs
Average Volume
450,723 shs
Market Capitalization
$333.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.96

KalVista Pharmaceuticals (NASDAQ:KALV) SEC Filings

DateFilerForm TypeView
09/15/2021
6:00 AM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2021
3:19 PM		KalVista Pharmaceuticals (Filer)
Form DEF 14A
06/30/2021
6:30 AM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2021
4:15 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
6:29 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
10:37 AM		FMR LLC (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
06/07/2021
6:15 AM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2021
5:28 PM		KalVista Pharmaceuticals (Issuer)
Smith Michael David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
5:26 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
11:15 PM		KalVista Pharmaceuticals (Filer)
Form EFFECT
05/28/2021
4:29 PM		KalVista Pharmaceuticals (Issuer)
Smith Michael David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
4:28 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
4:26 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
4:25 PM		KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
4:23 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
4:20 PM		KalVista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:44 PM		KalVista Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
05/07/2021
5:05 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4/A
05/06/2021
7:06 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
7:03 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
4:36 PM		Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
4:32 PM		Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2021
4:49 PM		KalVista Pharmaceuticals (Issuer)
Smith Michael David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
7:55 PM		KalVista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
6:49 PM		KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
6:46 PM		KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2021
4:24 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2021
4:18 PM		KalVista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2021
4:15 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
7:25 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
7:23 PM		KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
7:22 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
7:20 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
7:31 AM		Ikarian Capital, LLC (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
02/10/2021
8:09 PM		KalVista Pharmaceuticals (Filer)
Form S-3MEF
02/08/2021
8:35 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
8:35 PM		KalVista Pharmaceuticals (Issuer)
Smith Michael David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
8:34 PM		KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
8:33 PM		KalVista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
8:33 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
8:32 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
9:25 AM		FMR LLC (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
01/27/2021
5:02 AM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
4:33 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
5:06 PM		KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
5:13 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
5:08 PM		KalVista Pharmaceuticals (Issuer)
Smith Michael David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
5:05 PM		KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
5:02 PM		KalVista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
5:01 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:58 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:05 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2020
3:30 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2020
3:05 PM		KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/01/2020
3:13 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
5:30 AM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
4:03 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2020
6:56 PM		Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
7:01 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2020
4:36 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2020
4:34 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2020
4:33 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
1:14 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
1:11 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
1:08 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:40 PM		KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:39 PM		Edwards Martin (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:38 PM		KalVista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:37 PM		KalVista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:36 PM		KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:35 PM		KalVista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:32 PM		Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
3:15 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
3:30 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
3:15 PM		KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/25/2020
3:15 PM		KalVista Pharmaceuticals (Filer)
Form DEF 14A
07/01/2020
3:16 PM		KalVista Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2020
1:01 PM		FMR LLC (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
03/23/2020
3:28 PM		Ikarian Capital, LLC (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G
03/10/2020
3:30 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2020
11:45 AM		Flynn James E (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
4:18 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
4:17 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
4:14 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:32 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
4:30 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
6:34 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
6:32 PM		Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
3:30 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
4:26 PM		Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
4:25 PM		KalVista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
4:24 PM		KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
3:00 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
4:23 PM		KalVista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:18 PM		KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/09/2019
3:15 PM		KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
6:20 AM		KalVista Pharmaceuticals (Filer)
Form DEF 14A
07/30/2019
6:37 PM		Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
4:53 PM		KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
4:52 PM		Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.